"The greatest glory in living lies not in never falling, but in rising every time we fall." – Nelson Mandela
Retatrutide is a once-weekly injectable therapy for the treatment of obesity and type 2 diabetes. It functions as a triple receptor agonist targeting GIP, GLP-1, and glucagon pathways. Unlike existing GLP-1–only therapies, Retatrutide works through a broader mechanism: GLP-1 activity helps regulate appetite, GIP influences fat metabolism, and glucagon signaling may increase energy expenditure.
Retatrutide is a once-weekly injectable therapy for the treatment of obesity and type 2 diabetes. It functions as a triple receptor agonist targeting GIP, GLP-1, and glucagon pathways. Unlike existing GLP-1–only therapies, Retatrutide works through a broader mechanism: GLP-1 activity helps regulate appetite, GIP influences fat metabolism, and glucagon signaling may increase energy expenditure.
Reviews
There are no reviews yet.